Results 91 to 100 of about 14,795,110 (295)

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

VAERS : Vaccine Adverse Event Reporting System : a national program for monitoring vaccine safety

open access: yes
The Vaccine Adverse Event Reporting System (VAERS), is a national program managed by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S.

core   +1 more source

Characteristics and risk factors of serious adverse drug reactions in older patients using the Korea Adverse Event Reporting System data: a retrospective observational study [PDF]

open access: yesJournal of Yeungnam Medical Science
Background Older adults are vulnerable to adverse drug reactions (ADRs) owing to physiological changes, comorbidities, and polypharmacy. Nationwide evidence in Korean is limited.
Minkyung Oh
doaj   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein   +7 more
wiley   +1 more source

An Overview of Clinical Pharmacology of Ibuprofen

open access: yesOman Medical Journal, 2010
Ibuprofen was the first member of Propionic acid derivatives introduced in 1969. It is a popular domestic and over the counter analgesic and antipyretic for adults and children.
Nousheen Aslam, Rabia Bushra
doaj  

Medication-related adverse events in older Brazilians [PDF]

open access: yesGeriatrics, Gerontology and Aging
Objective: To describe suspected adverse drug events in older adults reported in VigiMed, the Brazilian National Health Surveillance Agency’s reporting system.
Gabriela Oliveira Buzelin Doria   +7 more
doaj   +1 more source

Spontaneous Adverse Drug Reaction Reporting Vs Event Monitoring: A Comparison

open access: yes, 1991
Spontaneous adverse drug reaction (ADR) reporting is the mainstay of national and international drug safety evaluation in the post-approval phase. A major criticism of the method has been a high, but essentially unquantifiable, level of under-reporting ...
A P Fletcher
core   +1 more source

Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country:A Case Study from Ghana [PDF]

open access: yes, 2017
Recent efforts to introduce direct patient reporting into pharmacovigilance systems have proved that patient reports contribute significantly to medicine safety, but there is a paucity of information relating to patients' perspectives regarding adverse ...
van Puijenbroek, Eugène   +11 more
core   +1 more source

Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries

open access: yesPharmacology Research & Perspectives
This study assessed whether the completeness of spontaneously reported adverse drug reaction (ADR) reports differs between consumers and healthcare professionals when submitted directly to regulators, and how this compares to reports from pharmaceutical ...
Mohammed Gebre Dedefo   +5 more
doaj   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy